These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Effect of a new beta-receptor blockader (LB 46, Visken) on systemic and pulmonary hemodynamics and on coronary blood flow in humans]. Dolder M; Kaufmann M; Gurtner HP Schweiz Med Wochenschr; 1971 Dec; 101(51):1869-76. PubMed ID: 4400986 [No Abstract] [Full Text] [Related]
24. [Effects of isosorbide dinitrate on systemic haemodynamics, regional coronary blood flow and ST-segment. A study on normal and/or ischaemic dog heart (author's transl)]. Berdeaux A; Giudicelli JF Nouv Presse Med; 1982 Jun; 11(27):2043-7. PubMed ID: 7110963 [TBL] [Abstract][Full Text] [Related]
25. Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium. Evans DB; Parham CS; Laffan RJ Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):240-8. PubMed ID: 41496 [No Abstract] [Full Text] [Related]
26. Effects of nifedipine on coronary and systemic hemodynamics in the conscious dog. Gross R; Kirchheim H; von Olshausen K Arzneimittelforschung; 1979; 29(9):1361-8. PubMed ID: 42417 [No Abstract] [Full Text] [Related]
28. [Effects of nicardipine on regional coronary deficit and the ST segment of the healthy and ischemic myocardium in dogs]. Berdeaux A; Giudicelli JF J Pharmacol; 1985; 16(1):59-74. PubMed ID: 3999752 [TBL] [Abstract][Full Text] [Related]
29. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)]. Kubota M; Gotho Y; Furukawa K Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404 [No Abstract] [Full Text] [Related]
30. [Beta-adrenolytic and electrocardiographic effects using pitressin]. Marmo E; Coscia L; Aulisio GA Angiologica; 1967; 4(5):256-70. PubMed ID: 4157291 [No Abstract] [Full Text] [Related]
31. [Pharmacology of nitrites and adrenergic beta blockaders in coronary circulation]. Méndez R Arch Inst Cardiol Mex; 1980; 50(3):283-88. PubMed ID: 6107070 [No Abstract] [Full Text] [Related]
32. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. Schliep HJ; Harting J J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774 [TBL] [Abstract][Full Text] [Related]
33. [The effect of nitrates, beta blockaders and revascularization on myocardial circulation in patients with coronary heart disease (proceedings)]. Fleck E Fortschr Med; 1979 May; 97(17):824. PubMed ID: 35453 [No Abstract] [Full Text] [Related]
34. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs. Heng MK; Singh BN; Norris RM; John MB; Elliot R J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347 [TBL] [Abstract][Full Text] [Related]
35. Antianginal and haemodynamic effects of a new beta-blocking agent, SD 1601. Radice M; Folli G; Tavecchia A; Mariotti G; Cameroni E Arzneimittelforschung; 1978; 28(11):2160-3. PubMed ID: 40567 [TBL] [Abstract][Full Text] [Related]
36. Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium. Buck JD; Gross GJ; Warltier DC; Jolly SR; Hardman HF Am J Cardiol; 1979 Oct; 44(4):657-63. PubMed ID: 39449 [No Abstract] [Full Text] [Related]
37. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601]. Marchetti G; Merlo L; Noseda V Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148 [No Abstract] [Full Text] [Related]
38. [Automatic evaluation of thoracic and epicardic electromaps in experimental acute infarct. Effect of a new beta-moderating drug on the extent of the ischemic area]. Taccadi B; Macchi E; De Ambroggi L Boll Soc Ital Cardiol; 1975; 20(10):1293-302. PubMed ID: 10932 [No Abstract] [Full Text] [Related]
39. [Mechanism of action of the new beta-adrenolytic drug VUL 111 upon the cardiovascular system. 1. Beta-adrenolytic activity on peroral administration and ways of metabolic degradation (author's transl)]. Drimal J; Strízová K; Borovicová F; Gibala P; Stefek M; Kovácik V Bratisl Lek Listy; 1978 Jul; 70(1):11-28. PubMed ID: 28818 [No Abstract] [Full Text] [Related]